This position paper presents facts and figures regarding the evolution of interactions between pharma companies and physicians, and makes practical recommendations to ensure regular and impactful interactions in the years to come
News
« High-performance Market Access Brand Plans require method, rigor and pragmatism » Our new publication on how to build...
This new paper highlights our analyses on:
Based on the analysis of the most recent data and trends (gathered in The Global Pharma Market...